Patient-Initiated and ConTrolled Oral Refeeding (PICTOR) (PICTOR)

September 24, 2019 updated by: Max Petrov, University of Auckland, New Zealand

A Randomized Controlled Trial of Patient-Initiated and ConTrolled Oral Refeeding in Acute Pancreatitis

The first step in treating patients with acute pancreatitis is to provide pain relief and intravenous fluids to keep them comfortable. As the pain subsides and patient starts to feel better food and fluids by mouth are restarted. This is done to rest the pancreas which is the organ that has been inflamed.

In some patients when food by mouth restarts they have pain and as a consequence they have a longer stay in hospital. It is thought that patients who have little pain and are within 24 hours of admission to hospital do well if they control their own food intake. This is in contrast to the usual treatment where the treating team advise when eating should restart.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Auckland, New Zealand
        • University of Auckland; Auckland City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosis of acute pancreatitis
  • age > 18 years
  • written informed consent

Exclusion Criteria:

  • ongoing need for opiates
  • >96 hours after onset of symptoms
  • chronic pancreatitis
  • post-ERCP pancreatitis
  • intraoperative diagnosis
  • pregnancy
  • malignancy
  • received nutrition before randomisation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Conventional management
Experimental: Patient-controlled oral refeeding
Patients will be allowed to drink and eat hospital food freely as tolerated.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Oral food intolerance
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time from admission until tolerance of oral food
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Total length of hospital stay
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Need for opiates
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days

Need for opiates is defined when one (or more) of the following has been administered:

  • Codeine phosphate
  • Fentanyl
  • Morphine, Sevredol, Meslon
  • Oxynorm, Oxycodone
  • Tramadol
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Change in pain intensity
Time Frame: Baseline and 24, 48, 72h after randomisation
Baseline and 24, 48, 72h after randomisation
Progression of acute pancreatitis severity
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
To be defined according to the 2012 determinant-based classification of acute pancreatitis severity
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Hospital readmission
Time Frame: 2 weeks after hospital discharge
2 weeks after hospital discharge
Local and systemic complications
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
To be defined according to the 2012 determinant-based classification of acute pancreatitis severity
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Number and type of interventions during hospital stay
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Time from admission until first flatus
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Change in blood glucose
Time Frame: Baseline and 24, 48, 72h after randomisation
Baseline and 24, 48, 72h after randomisation
Change in plasma C-reactive protein
Time Frame: Baseline and 24, 48, 72h after randomisation
Baseline and 24, 48, 72h after randomisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2013

Primary Completion (Actual)

June 1, 2018

Study Completion (Actual)

June 1, 2019

Study Registration Dates

First Submitted

November 5, 2012

First Submitted That Met QC Criteria

November 13, 2012

First Posted (Estimate)

November 20, 2012

Study Record Updates

Last Update Posted (Actual)

September 26, 2019

Last Update Submitted That Met QC Criteria

September 24, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • NTX/12/06/051

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pancreatitis

Clinical Trials on Patient-controlled oral refeeding

3
Subscribe